Mel Mann is the World’s Longest Living Gleevec (Imatinib) & TKI & Kinase Inhibitor Survivor, 27 Year Terminal Leukemia (CML) Survivor; US Army Retired, Educator, Patient Advocate & Consultant. He Published and appeared in articles such as USA Today, Coping With Cancer Magazine, American Association for Cancer Research (AACR), Cancer Today Magazine etc. He also appeared on numerous television & radio shows as a patient advocate and made a nationwide television commercial for the American Cancer Society (ACS). He has participated on panels such as The Atlantic’s People vs Cancer series, Hematology Oncology Pharmacy Association (HOPA), WCG, Patient Power etc. Mel Mann actively collaborates on health equity and ethnic diversity issues with groups such as the American Cancer Society’s Cancer Action Network (ACSCAN), Society of Integrative Oncology (SIO) etc. He has participated in numerous nationwide bone marrow drives, including the World’s Largest, with 10,675 people joining the marrow registry at a single drive and collaborated in marrow donor recruitment for Be The Match, DKMS Marrow, and the Bill Young Marrow Donor organizations. He is the past National Community Outreach Coordinator of Leukemia & Lymphoma Society’s (LLS) Myeloma Link program. He has been a Guest Speaker for Cepheid, Churches, Community Organizations, Leukemia & Lymphoma Society, Cancer Support Groups and the US Army. For being a marrow donor, please visit: http://join.bethematch.org/MelMann.